ReviewAdvances in nutrition (Bethesda, Md.)2026
A Critical Review of the Science on "Highly" Processed Food Intake and Body Weight.
Review in Advances in nutrition (Bethesda, Md.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Recognition of Food Processing and Its Association with Consumption Patterns and Nutrient Intake Among Saudi University Students.Foods (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There is increasing consideration of food processing and formulation in setting dietary guidance at the state, federal, and global levels to manage obesity and other health conditions. However, the supporting evidence base is highly controversial. This stems, in part, from the lack of a widely accepted definition of highly or ultraprocessed foods and beverages (HPFB) and evidence that published definitions hold different predictive health risks. The preponderance of evidence linking food processing and formulation practices to health outcomes is drawn from observational studies. This literature generally suggests that HPFB intake is associated with a higher risk of obesity. However, a critical assessment indicates that the associations are weak and inconsistent. More recently, a number of randomized controlled trials have been published based on educational, community-based dietary and metabolic ward feeding interventions. Metabolic ward trials involved small samples, short-term assessment, and ecologically questionable comparisons. They reported no changes in appetite, and only transient shifts in food intake. The community-based trials generally have high attrition rates and use no objective measure of dietary compliance with the intervention. They reveal that the implementation of interventions to moderate HPFB intake is often not achieved. No community-based trial has observed weight gain on the high HPFB treatment arm, and only half report a significant group weight differential. Among all trials, the intake of HPFB has led to increased, no change, and decreased body weight. To date, they do not adequately support a causal relationship between HPFB intake and obesity risk. Given the tangible likely adverse effects of eliminating HPFB from the diet, such as increased food-borne illness, greater food waste, as well as decreased diet quality, increased food cost, and reduced convenience, especially for segments of the population least able to tolerate such changes, dietary guidance based solely on the HPFB concept is, presently, not in the public's best interest.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.